...business development and strategy and investor relations.Prior to Merck, Davis had a 10-year tenure at Baxter International...

...pharmas. Pfizer acquired Bamboo in 2016, while Baxter International...

...tumor specificity.” The target was first identified as a tumor antigen by a team of Baxter International...

...as CFO of EryDel S.p.A., Egalet Corp., Strategic Diagnostics Inc. and Prism Pharmaceuticals Inc., which Baxter International...

...Laboratories; Brent Saunders, chairman and CEO, Allergan plc; José (Joe) Almeida, chairman, president and CEO, Baxter International...
...Companies and Institutions Mentioned Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. Allergan plc (NYSE:AGN), Dublin, Ireland Baxter International...
...Inc. (NASDAQ:OVID), New York, N.Y. Pfizer Inc. (NYSE:PFE), New York, N.Y. Steve Usdin, Washington Editor Abbott Laboratories AbbVie Inc. Baxter International...

...hemophilia company Chatham Therapeutics LLC. Pfizer acquired Bamboo in 2016. Following a 2014 deal with Baxter International...

...job business development experience in Asia through prior positions at Aeras Global TB Vaccine Foundation, Baxter International...
...significant opportunities for innovation. Companies and Institutions Mentioned Aeras Global TB Vaccine Foundation, Rockville, Md. Baxter International...

...Drug Abuse (NIDA) to support development of OPNT003. Revex, an injectable formulation of nalmefene from Baxter International...

...Drug Abuse (NIDA) to support development of OPNT003. Revex, an injectable formulation of nalmefene from Baxter International...

...Helen Torley told BioCentury that at the time of Halozyme’s first deals with Roche and Baxter International...
...after ViroPharma Inc. was acquired by Shire plc (LSE:SHP; NASDAQ:SHPG) in 2014; (C) In 2015, Baxter International...
...ViroPharma Inc. (B) 1 Inflammation Subcutaneous Cinryze (C1 esterase inhibitor) $9 $74 $83 10% 05/11/11 Baxter International...